Every 8-K that AirSculpt Technologies, Inc. (AIRS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow AIRS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AIRS filings page.
AirSculpt Technologies, Inc. disclosed that its Board of Directors approved relocating the company’s corporate headquarters. The headquarters will move from 1111 Lincoln Road, Suite 802, Miami Beach, Florida 33139 to 2023 West Platt Street, Tampa, Florida 33605, effective for corporate records and reporting purposes.
The new Tampa address will appear in the company’s future periodic reports and other filings with the Securities and Exchange Commission. No operational, financial, or transactional terms are described beyond this change of corporate headquarters address.
AirSculpt Technologies, Inc. reported softer second-quarter 2026 results while highlighting modest operational stability and debt reduction. Q2 revenue was $42.9 million, down from $44.0 million a year earlier, with case volume essentially flat at 3,376 and revenue per case slightly lower. The company recorded a net loss of $1.1 million versus a $0.6 million loss in Q2 2025, and Adjusted EBITDA declined to $4.9 million from $5.8 million, reducing Adjusted EBITDA margin to 11.5% from 13.3%.
For the first six months of 2026, revenue was $82.3 million and net loss $3.5 million, both similar to 2025, while Adjusted EBITDA fell to $8.2 million. Same-center case volume grew about 1% in Q2 and year-to-date, but same-center revenue per case decreased. Management reaffirmed 2026 revenue at the lower end of its $151–$157 million guidance range and reduced its Adjusted EBITDA outlook to $12–$14 million.
Liquidity improved, with $18.8 million of cash and gross debt of $44.2 million as of June 30, 2026, reflecting roughly $30 million of gross debt reduction and about $10 million higher cash since the start of 2025. The company amended its term loan to extend maturity to November 2027, made a $2.5 million payment at signing, committed to another $2.5 million by September 30, 2026, and earmarked 50% of future equity issuance net proceeds for additional prepayments.
AirSculpt Technologies, Inc. held its 2026 annual stockholder meeting virtually on May 12, 2026. A total of 65,895,278 shares of Class A common stock were present or represented by proxy, which was 93.49% of the 70,486,528 shares entitled to vote as of March 13, 2026.
Stockholders elected three Class II directors—Adam Feinstein, Thomas Aaron, and Kenneth Higgins—to serve until the 2029 annual meeting. Each nominee received more than 33.8 million votes "for," with broker non-votes reported on this proposal.
Stockholders also ratified the selection of Grant Thornton LLP as the company’s independent registered public accounting firm for the year ending December 31, 2026, with 41,551,299 votes for, 24,343,978 against, and 1 abstention. No other matters were submitted for a vote.
AirSculpt Technologies reported first-quarter 2026 results with stable revenue and a smaller loss. Revenue was $39.4 million, essentially flat with the prior-year quarter, while case volume edged up to 3,082 and same-center sales increased 1%.
Net loss improved to $2.4 million from $2.8 million, and Adjusted EBITDA declined to $3.3 million from $3.8 million, with an Adjusted EBITDA margin of 8.4%. The company reaffirmed full-year 2026 guidance for revenue of approximately $151 to $157 million and Adjusted EBITDA of approximately $15 to $17 million. Cash and cash equivalents rose to $16.7 million as of March 31, 2026, aided by $14.6 million raised under an at-the-market equity program and $11.4 million of debt repayment, reducing long-term debt while maintaining compliance with all covenants.
AirSculpt Technologies, Inc. filed an amended current report to correct errors in certain non-GAAP figures in its earlier earnings release, then reiterated updated fourth-quarter and full-year 2025 results and 2026 guidance. The corrections reduced Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Net (Loss)/Income for the three and twelve months ended December 31, 2025, mainly due to a one-time non-cash adjustment tied to closing its London facility and a tax-effect adjustment.
For Q4 2025, case volume fell 15.0% to 2,604 and revenue declined 14.6% to $33.4 million, but net loss improved to $1.3 million from $5.0 million a year earlier; Adjusted EBITDA was roughly breakeven at $(0.1) million. For full-year 2025, cases fell 15.6% to 11,852, revenue declined 15.8% to $151.8 million, net loss widened to $11.7 million, and Adjusted EBITDA decreased to $12.5 million.
The company ended 2025 with $8.4 million in cash, $56.0 million of gross debt and $87.7 million of stockholders’ equity, and remained in compliance with debt covenants. In Q1 2026, it raised $14.8 million via its at-the-market share program and paid down $11.0 million of debt, reducing gross debt to about $45.0 million. Management projects 2026 revenue of $151–$157 million and Adjusted EBITDA of $15–$17 million, and notes that the non-GAAP corrections do not affect GAAP financial statements or 2026 forward-looking guidance.
AirSculpt Technologies reported weaker 2025 results but a stronger fourth quarter and issued 2026 guidance. Full-year 2025 revenue fell 15.8% to $151.8 million, with case volume down 15.6% to 11,852. The company posted a net loss of $11.7 million versus $8.0 million in 2024, while Adjusted EBITDA declined to $15.1 million from $21.0 million.
Fourth-quarter trends improved, with revenue of $33.4 million, a smaller net loss turning into net income of $1.3 million, and Adjusted EBITDA rising to $2.5 million, lifting margin to 7.4% from 4.9%. Same-center revenue per case grew modestly despite lower case counts.
For 2026, the company guides to revenue of $151–$157 million and Adjusted EBITDA of $15–$17 million. As of December 31, 2025, AirSculpt held $8.4 million in cash and $56.0 million of gross debt, later reduced to about $45.0 million after raising $14.8 million through an at-the-market equity program and repaying $11.0 million of debt.
AirSculpt Technologies plans to file a Form 12b-25 to delay its Form 10-K for fiscal 2025, citing the need for more time to complete the classification of inter-company transactions and balances. The company expects to file the annual report within the 15‑day grace period.
AirSculpt released preliminary, unaudited results showing fiscal 2025 revenue of $151.8 million and fourth quarter 2025 revenue of $33.4 million, with same-store revenue down about 16% in the quarter but improving to down single digits in December. For first quarter 2026, it expects revenue of $38.5–$39.5 million, implying roughly flat same-store revenue at the midpoint after positive comparable sales in February. As of March 13, 2026, cash was $13.0 million and debt was $46.0 million, which the company characterizes as a strong balance sheet and enhanced liquidity.
AirSculpt Technologies, Inc. appointed Michael Doyle as a Class III director and the Non-Executive Chairman of the Board, effective November 14, 2025. He will stand for election by stockholders at the company’s 2027 annual meeting. Doyle is an experienced healthcare services executive, currently Managing Partner of Vesey Street Capital Partners and formerly CEO of Surgery Partners, where he led the business for about 15 years and expanded it from 3 to over 175 locations. He has also chaired several physician and dental organizations and previously served on the board of managers of Elite Body Sculpture, the company’s predecessor before its IPO. The board determined that he qualifies as an independent director under Nasdaq rules, and he will not receive compensation for serving as a director and Non-Executive Chairman. The company also filed a press release as an exhibit to this report.
AirSculpt Technologies announced quarterly results and updated 2025 revenue guidance and Adjusted EBITDA guidance via press release, and named Michael Arthur as Chief Financial Officer, effective January 5, 2026.
Arthur’s compensation includes a $400,000 annual base salary, target cash bonus equal to 50% of salary (from fiscal 2026), a $100,000 sign‑on cash bonus, and a $600,000 sign‑on equity grant split between RSUs ($300,000) and PSUs ($300,000). RSUs vest over three years; PSUs vest over three years based on relative total shareholder return with achievement from 0% to 200%. Severance provides nine months’ salary and COBRA contributions, or upon a change in control, a lump sum of salary plus target bonus, 12 months’ COBRA contributions, full RSU acceleration, and PSU conversion as described.
AirSculpt Technologies (AIRS) announced a leadership change. On November 4, 2025, Dr. Aaron Rollins resigned as executive chairman and as a member of the board of directors, effective the same day.
The company stated that Dr. Rollins’ resignation was not due to any disagreements with the company, its management, or the board on matters related to operations, policies, or practices. The filing lists no additional board or management changes or interim appointments.